3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
43
Leukemia
17
Recurrence
7
Lymphoma
7
Burkitt Lymphoma
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Leukemia, Biphenotypic, Acute
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Non-Hodgkin
2
Leukemia, T-Cell
2
Leukemia, Myeloid, Acute
2
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Multiple Myeloma
1
Lymphoproliferative Disorders
1
Lymphoma, T-Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphoid
1
Leukemia, B-Cell
1
Immunoproliferative Disorders
1
Hodgkin Disease
1
Fallopian Tube Neoplasms
1
Drug-Related Side Effects and Adverse Reactions
1
Down Syndrome
1
Blast Crisis
1
Interventions
Rituximab
5
Valganciclovir
2
Methotrexate
2
Leucovorin
2
Doxorubicin
2
valomaciclovir
1
threonic acid
1
pembrolizumab
1
otelixizumab
1
merphos
1
cc-486
1
avelumab
1
Zidovudine
1
Vincristine
1
Valacyclovir
1
Tomography, X-Ray Computed
1
Prednisone
1
Magnesium Sulfate
1
Interferons
1
Hydroxyurea
1
Etoposide
1
Echocardiography
1
EPOCH protocol
1
Cyclophosphamide
1
Caves
1
Carboplatin
1
Brentuximab Vedotin
1
Bortezomib
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Epstein-Barr Virus Infections
×
pegaspargase
×
Clear all
No trials found.